BENTSUR RON

Average Profitability
27.3%
Insider Buys Quantity
58
Insider Buys Sum
$3.58M
Insider Sells Quantity
26
Insider Sells Sum
$1.51M

Insider Activity of BENTSUR RON

According to the SEC Form 4 filings, BENTSUR RON, being in a position of

  1. Chairman & CEO at Nuvectis Pharma, Inc.,
    оver the last 12 months, has bought 33440 shares for $196,651, and sold 0 shares,
    over all time since 2022-02-04, has bought 610175 shares for $3.54M, and sold 0 shares.

The largest purchase of all time was on 2022-02-04 and amounted to 425000 shares of Nuvectis Pharma, Inc. for $2.1M.

The largest sale of all time was on 2021-11-24 and amounted to 37464 shares of Beyond Air, Inc. for $507,071.

Biography of BENTSUR RON

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Prismo
Buys
 $196,6515100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

Prismo
Prismo
2024-12-24PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
4,500
0.0233%
$4.65$20,925+40.86%
2024-11-15PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
20,000
0.0887%
$4.92$98,400+23.23%
2024-05-14PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
1,940
0.0105%
$6.74$13,076-3.99%
2024-05-10PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
2,000
0.0109%
$6.40$12,800+1.56%
2024-03-18PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
5,000
0.0283%
$10.29$51,450-37.46%
2023-10-10PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
640
0.0038%
$11.08$7,091-33.95%
2023-10-09PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
830
0.0049%
$11.19$9,288-34.72%
2023-10-06PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
250
0.0014%
$11.27$2,818-36.77%
2023-10-05PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
1,400
0.0076%
$11.09$15,526-34.22%
2023-10-04PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
1,820
0.0098%
$10.95$19,929-34.82%
2023-08-16PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
115
0.0008%
$15.15$1,742-43.03%
2023-08-15PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
235
0.0015%
$14.34$3,370-42.41%
2023-08-11PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
180
0.0011%
$14.66$2,639-46.47%
2023-08-08PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
120
0.0008%
$14.83$1,780-44.59%
2023-07-21PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
225
0.0015%
$14.85$3,341-44.81%
2023-07-20PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
110
0.0008%
$15.06$1,657-41.95%
2023-07-19PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
200
0.0013%
$14.33$2,866-42.75%
2023-07-14PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
150
0.001%
$15.03$2,255-44.26%
2023-07-07PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
110
0.0008%
$16.19$1,781-45.01%
2023-07-06PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
320
0.0021%
$14.88$4,762-44.8%
Total: 84
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD